Page last updated: 2024-09-03

bn 52063 and Shock, Septic

bn 52063 has been researched along with Shock, Septic in 2 studies

*Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guinot, P1
Braquet, P; Etienne, A; Guilmard, C; Hecquet, F; Soulard, C1

Reviews

1 review(s) available for bn 52063 and Shock, Septic

ArticleYear
Clinical experience with platelet-activating factor antagonists. Past, present, and near future.
    Clinical reviews in allergy, 1994,Winter, Volume: 12, Issue:4

    Topics: Animals; Azepines; Clinical Trials as Topic; Graft Rejection; Humans; Kidney Transplantation; Lactones; Plant Extracts; Platelet Activating Factor; Randomized Controlled Trials as Topic; Shock, Septic; Thienopyridines; Triazoles

1994

Other Studies

1 other study(ies) available for bn 52063 and Shock, Septic

ArticleYear
Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    International journal of tissue reactions, 1987, Volume: 9, Issue:1

    Topics: Animals; Diterpenes; Endotoxins; Ginkgolides; Lactones; Male; Phospholipases A; Plant Extracts; Platelet Activating Factor; Protease Inhibitors; Rats; Rats, Inbred Strains; Shock, Septic; Trypsin

1987